|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 7/08 | |
| C07K 14/00 | |||
| G01N 33/68 | |||
| A61K 39/395 | |||
| C07K 14/005 |
| (11) | Number of the document | 2859011 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13727202.7 |
| Date of filing the European patent application | 2013-06-06 | |
| (97) | Date of publication of the European application | 2015-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/061751 |
| Date | 2013-06-06 |
| (87) | Number | WO 2013/182661 |
| Date | 2013-12-12 |
| (30) | Number | Date | Country code |
| 201261656256 P | 2012-06-06 | US |
| (72) |
S RENSEN, Birger, NO
ÖKVIST, Mats, NO
HOVDEN, Arnt Ove, NO
GR NVOLD, Maja Sommerfelt, NO
|
| (73) |
Bionor Immuno AS,
Klostergata 33 P.O. Box 2870, 3702 Skien,
NO
|
| (54) | PEPTIDES DERIVED FROM VIRAL PROTEINS FOR USE AS IMMUNOGENS AND DOSAGE REACTANTS |
| PEPTIDES DERIVED FROM VIRAL PROTEINS FOR USE AS IMMUNOGENS AND DOSAGE REACTANTS |